RESEARCH-USE BIOSIMILAR ANTIBODY

Nesvacumab

Monoclonal antibody · IgG1

ANGPT2IgG1RUO

Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Angiopoietin-2 (Ang2) with high affinity, but shows no binding to Ang1. Nesvacumab can be used in vascular researches.

TARGETANGPT2
YMonoclonal antibody
CATALOGSC-BS-350
CATALOG NUMBERSC-BS-350
MOLECULAR WEIGHTApprox. 144.86 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Nesvacumab is a fully human immunoglobulin G1 (IgG1) monoclonal antibody that specifically binds and inactivates the Tie2 receptor ligand Angiopoietin-2 (Ang2) with high affinity, but shows no binding to Ang1. Nesvacumab can be used in vascular researches.

Nesvacumab is a recombinant research-use antibody directed against ANGPT2.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Nesvacumab | StellaCyte